Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Activation of Integrins01:15

Activation of Integrins

5.7K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

8.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

3.2K
3.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.9K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.9K
Integrins01:10

Integrins

6.2K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RAP1-RHO small GTPase cross-talk mediates integrin-dependent and -independent platelet procoagulant response.

Haematologica·2026
Same author

Regulated RIAM-Talin Engagement Controls Adhesion Stability and Mechanical Output.

bioRxiv : the preprint server for biology·2026
Same author

A CD25-chemokine receptor complex initiates noncanonical IL-2 signaling.

The Journal of biological chemistry·2025
Same author

RAP1-RHO small GTPase cross-talk mediates integrin-dependent and -independent platelet procoagulant response.

bioRxiv : the preprint server for biology·2025
Same author

Silencing <i>KRIT1</i> Partially Reverses the Effects of Disturbed Flow on the Endothelial Cell Transcriptome.

International journal of molecular sciences·2025
Same author

Silencing <i>KRIT1</i> Partially Reverses the Effects of Disturbed Flow on the Endothelial Cell Transcriptome.

bioRxiv : the preprint server for biology·2025
Same journal

Enhancement of ferroptosis in escape variant tumor cells by IFN-γ derived from antigen-specific T cells controls tumor with heterogeneity.

Cancer immunology research·2026
Same journal

CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance.

Cancer immunology research·2026
Same journal

Coordinated immune activation following KRAS inhibition in syngeneic models reveals molecular pathways that potentiate and limit antitumor immunity.

Cancer immunology research·2026
Same journal

VISTA+ neutrophils contribute to platinum resistance by suppressing CD8+T cells in high-grade serous ovarian cancer.

Cancer immunology research·2026
Same journal

A Sampling of Highlights from the Literature: Article Recommendations from Our Deputy and Senior Editors.

Cancer immunology research·2026
Same journal

Multinucleated giant cells in human pancreatic cancer are a distinct macrophage population undergoing a DNA damage response and associated with an aggressive tumor microenvironment.

Cancer immunology research·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K

Fine-tuning Tumor Immunity with Integrin Trans-regulation.

Joseph M Cantor1, David M Rose2, Marina Slepak2

  • 1Department of Medicine, University of California, San Diego, La Jolla, California. jmcantor@ucsd.edu mhginsberg@ucsd.edu.

Cancer Immunology Research
|January 21, 2015
PubMed
Summary
This summary is machine-generated.

Modifying alpha4 integrin enhances T-cell homing to tumors by increasing alphaLbeta2 integrin activity. This improved T-cell migration boosts anti-tumor immunity and reduces melanoma growth.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.9K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

2.1K

Related Experiment Videos

Last Updated: Apr 18, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.9K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

2.1K

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • T-cell homing to solid tumors is crucial for adoptive T-cell immunotherapy but is often inefficient.
  • Integrins alphaLbeta2 and alpha4beta1 mediate T-cell trafficking by binding ICAM-1 and VCAM-1, respectively.
  • Protein kinase A (PKA)-mediated phosphorylation of alpha4 integrin regulates T-cell migration via 'integrin trans-regulation'.

Purpose of the Study:

  • To investigate the in vivo effects of integrin trans-regulation by creating a mouse model with non-phosphorylatable alpha4 integrin (alpha4(S988A)).
  • To determine if altering alpha4 integrin phosphorylation impacts leukocyte trafficking to inflammatory sites and tumor immunity.

Main Methods:

  • Generated a mouse model expressing alpha4(S988A) integrin, preventing PKA-mediated phosphorylation.
  • Assessed leukocyte (lymphocyte and myeloid cell) migration to inflammatory sites in vivo.
  • Evaluated T-cell infiltration and B16 melanoma growth in alpha4(S988A) mice.

Main Results:

  • The alpha4(S988A) mouse model showed a significant and specific increase in lymphocyte migration, but not myeloid cells, to inflammation sites.
  • alpha4(S988A) mice demonstrated enhanced T-cell infiltration into B16 melanomas.
  • Tumor growth was reduced in alpha4(S988A) mice, correlating with increased T-cell infiltration.

Conclusions:

  • Increased alpha4 trans-regulation of alphaLbeta2 integrin function preferentially directs leukocyte emigration towards lymphocytes.
  • This targeted leukocyte trafficking enhances anti-tumor immunity and reduces melanoma growth.
  • Targeting alpha4 integrin phosphorylation represents a potential strategy to improve T-cell immunotherapy for solid tumors.